- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Metastatic Triple Negative
Total 12910 results
-
Hoffmann-La RocheBreast International Group; Frontier Science & Technology Research Foundation... and other collaboratorsCompletedTriple Negative Breast CancerRussian Federation, United States, Israel, Italy, Spain, France, Korea, Republic of, United Kingdom, Denmark, Taiwan, Hungary, Argentina, Australia, Austria, Belgium, Brazil, China, Germany, Hong Kong, Japan, Mexico, Romania, Switze... and more
-
Baylor Research InstituteEli Lilly and CompanyCompletedTriple Negative Breast CancerUnited States
-
Joyce O'ShaughnessyTakedaCompletedTriple Negative Breast CancerUnited States
-
Indiana UniversityCompletedTriple Negative Breast CancerUnited States
-
Peter MacCallum Cancer Centre, AustraliaTrans Tasman Radiation Oncology GroupCompleted
-
Jiangsu HengRui Medicine Co., Ltd.TerminatedBreast Cancer | Triple Negative Breast CancerChina
-
NYU Langone HealthNational Institutes of Health (NIH)TerminatedBreast Cancer | Triple Negative Breast CancerUnited States
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversitySuspended
-
SanofiTerminatedTriple Negative Breast CancerSpain, Belgium, Italy, Czechia, Netherlands
-
Marker Therapeutics, Inc.CompletedBreast CancerUnited States
-
Hebei Medical University Fourth HospitalWithdrawnTriple Negative Breast CancerChina
-
Leo W. Jenkins Cancer CenterTerminatedBreast CancerUnited States
-
University of Wisconsin, MadisonActive, not recruitingBreast Cancer | Triple Negative Breast CancerUnited States
-
German Breast GroupAstraZeneca; CelgeneCompleted
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Unknown
-
Fudan UniversityCompleted
-
AbbVieTerminated
-
Mario Negri Institute for Pharmacological ResearchAssociazione Italiana per la Ricerca sul CancroTerminated
-
University of VirginiaCelldex TherapeuticsWithdrawn
-
Hoffmann-La RocheCompletedBreast CancerUnited Kingdom
-
Genentech, Inc.Hoffmann-La RocheCompletedBreast CancerUnited States, Belgium, France, Germany, United Kingdom, Spain
-
Jules Bordet InstituteWithdrawnBreast CancerBelgium, France
-
National Taiwan University HospitalUnknownTriple Negative Breast CancerTaiwan
-
Istituti Ospitalieri di CremonaUnknownBreast Cancer | Triple Negative Breast Cancer
-
Istituti Ospitalieri di CremonaUnknownSafety and Tolerability of Everolimus in Combination With Eribulin in Triple-negative Breast CancersTriple Negative Breast CancerItaly
-
Cancer Institute and Hospital, Chinese Academy...Beijing Municipal Science & Technology CommissionActive, not recruitingTriple Negative Breast Cancer
-
Fudan UniversityZhejiang Cancer Hospital; Changhai Hospital; 307 Hospital of PLA; Sun Yat-sen University and other collaboratorsCompleted
-
Institut Paoli-CalmettesUnknown
-
Asan Medical CenterCompletedBreast CancerKorea, Republic of
-
Russian Academy of Medical SciencesCompletedInduction Preoperative Chemotherapy for Patients With Locally Advanced Triple Negative Breast CancerTriple Negative Breast CancerRussian Federation
-
Piramal Enterprises LimitedTerminated
-
Fudan UniversityNot yet recruitingTNBC - Triple-Negative Breast Cancer
-
Fudan UniversityNot yet recruitingBrain Metastasis | TNBCChina
-
Tongji HospitalRecruitingBreast Cancer | TNBC - Triple-Negative Breast Cancer | Estrogen-receptor-negative Breast CancerChina
-
M.D. Anderson Cancer CenterActive, not recruitingInvasive Breast Carcinoma | Triple-Negative Breast Carcinoma | Breast AdenocarcinomaUnited States
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI); Genentech, Inc.Active, not recruitingTriple Negative Breast Cancer | Invasive Breast Cancer | Stage IV Breast Cancer | HER2 NegativeUnited States
-
Alison StopeckRecruitingBreast Cancer | Triple Negative Breast Cancer | HER2-positive Breast Cancer | TNBC, Triple Negative Breast Cancer | Locally Advanced Breast Cancer | Neoadjuvant ChemotherapyUnited States
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI); Genentech, Inc.TerminatedTriple Negative Breast Cancer | Stage IV Breast Cancer | Triple-negative Breast Cancer | Recurrent Breast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Estrogen Receptor Negative Breast CancerUnited States
-
Zhejiang Cancer HospitalNot yet recruiting
-
Massachusetts General HospitalTesaro, Inc.RecruitingTriple Negative Breast Cancer | Residual DiseaseUnited States
-
Memorial Sloan Kettering Cancer CenterAstellas Pharma Inc; Medivation, Inc.Active, not recruitingBreast Cancer | Triple Negative Breast Cancer | Early StageUnited States
-
Oslo University HospitalKarolinska Institutet; Hoffmann-La Roche; Rigshospitalet, Denmark; Helse Stavanger... and other collaboratorsCompletedTriple Negative Breast Cancer | Cancer, BreastNorway, Denmark
-
Fudan UniversityTerminated
-
wang shusenNot yet recruitingBreast Cancer | Brain MetastasisChina
-
Centre Francois BaclesseRecruiting
-
Kari WisinskiPfizer; Celcuity IncActive, not recruitingTNBC - Triple-Negative Breast CancerUnited States
-
Laekna LimitedCompletedSolid Tumor | TNBC - Triple-Negative Breast CancerChina
-
ProDa BioTech, LLCEmory University; Georgia State UniversityNot yet recruitingTriple Negative Breast CancerUnited States
-
Tel Aviv Medical CenterNot yet recruitingTriple Negative Breast Cancer
-
Institut CurieNot yet recruitingTriple Negative Breast Cancer